%0 Generic
%A Ciruelos, E.
%A Salvador Bofill, F. J.
%A Perello Martorell, A.
%A Alba Conejo, E.
%A Gonzalez-Farre, X.
%A Palacios-Ozores, P.
%A Merino, M.
%A Villagrasa, P.
%A Vila Navarro, E.
%A Pascual, T.
%A Prat, A.
%A Pernas Simon, S.
%T SOLTI1710 PROMETEO II: Palbociclib in combination with letrozole in hormone receptor-positive (HR+)/HER2-negative residual disease after standard neoadjuvant chemotherapy (NAC)
%D 2021
%@ 0923-7534
%U https://hdl.handle.net/10668/27091
%~